Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
W. Li
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital,
Third Affiliated Hospital of Sun Yat-sen University
ORCID:
0009-0007-9273-3621
Observed ORCID:
0009-0007-9273-3621
OpenAlex ID:
A5008782240
Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study
2017
·
Q. Li
, H. Li
, et al.
·
Clinical & Translational Oncology
·
27
Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
2019
·
R. Liu
, X. Zhao
, et al.
·
Clinical & Translational Oncology
·
17
Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
2016
·
H. Jiang
, Q. Li
, et al.
·
Clinical & Translational Oncology
·
14
Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism
2013
·
X. He
, W. Li
, et al.
·
Journal of Vascular and Interventional Radiology
·
9
IMRT Versus 3D-CRT for Postmastectomy Irradiation of Chest Wall and Regional Nodes: A Population-Based Comparison of Normal Lung Dose
2014
·
W. Li
, J. Ma
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
6
450P Efficacy and safety of pyrotinib-based therapy in HER2-positive metastatic colorectal and gastric cancer: A retrospective study
2021
·
Q. Li
, T. Liu
, et al.
·
Annals of Oncology
·
3
Cetuximab Plus Mfolfox-6 As First-Line Therapy for Patients with Kras Wild-Type Unresectable Colorectal Liver-Limited Metastases: an Open, Non-Randomized, Multicenter Phase Ii Clinical Trial (Clime Study)
2014
·
S. Cai
, W. Zhang
, et al.
·
Annals of Oncology
·
2
PDF
Legumain is a predictive effector of peritoneal metastasis for diffuse gastric cancer patients
2019
·
Y. Wang
, Y. Cui
, et al.
·
Annals of Oncology
·
1
Quantitative Analyses of Early Tumor Shrinkage on Clinical Outcome in an Open, Non-Randomized, Multicenter Phase Ii Clinical Trial (Clime Study)
2014
·
W. Zhang
, S. Cai
, et al.
·
Annals of Oncology
·
1
PDF
560P Circulating tumor DNA guided therapeutic strategies for colorectal cancer patients with multiple small pulmonary-limited nodules: Updated results from the open-label, prospective, phase II cohort study
2024
·
J. Chang
, Y. Li
, et al.
·
Annals of Oncology
PDF
592P The role of early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
2023
·
J. Chang
, W. Du
, et al.
·
Annals of Oncology
PDF
1498P Phase I/II study to evaluate penpulimab combined with anlotinib and epirubicin in the first-line treatment of soft tissue sarcoma: Phase I dose escalation results
2022
·
Y. Zhou
, Y. Feng
, et al.
·
Annals of Oncology
PDF
Chest CT Features from 58 Patients with COVID-19 Pneumonia: From the Perspective of ACE2
2021
·
W. Li
, Y. Zhou
·
American Journal of Respiratory and Critical Care Medicine
456P Tumor response to irinotecan is associated with IL-10 expression level in metastatic colorectal cancer - Results from mCRC biomarker study
2020
·
J. Chang
, W. Zhang
, et al.
·
Annals of Oncology
475P Diffusion kurtosis imaging signature in predicting the chemotherapeutic response of colorectal liver metastases: The result of the FDZL-MRinCLM study
2020
·
W. Li
, H. Zhang
, et al.
·
Annals of Oncology
PDF
A 13-gene signature of DNA repair predicts prognosis in gastric cancer patients
2019
·
J. Chang
, M. Xu
, et al.
·
Annals of Oncology
Treatment Outcome for Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Analysis of 72 Cases
2012
·
X. Liu
, J. Cao
, et al.
·
Annals of Oncology
Cetuximab Plus Mfolfox-6 As First-Line Therapy for Unresectable Liver Metastasis from Colorectal Cancer: An Open, Non-Randomized, Multicenter Phase II Clinical Trial
2012
·
S. Cai
, W. Zhang
, et al.
·
Annals of Oncology
PDF
The Predictive Role of MTHFR and ABCG2 Single Nucleotide Polymorphisms on the Outcome of Advanced Colorectal Cancer Treated with First-Line Chemotherapy
2012
·
J. Zhao
, W. Zhang
, et al.
·
Annals of Oncology
Phase I dose-escalation study of thoracic radiotherapy in combination with gefitinib in patients with IIIB/IV non-small cell lung cancer (NCT00497250)
2009
·
M. Fan
, L. Xie
, et al.
·
Journal of Clinical Oncology
Prognostic factors for colorectal cancer patients with pulmonary metastases
2009
·
W. Li
, W. Zhang
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
21
Citation count:
80
H-index:
5
I10-index:
3
Year
Topic
Type